Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation 2024-11-13 00:54
Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders 2024-11-12 22:00
Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne 2024-11-12 19:30
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform 2024-11-11 23:00
Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes 2024-11-11 20:47
HKBN x INDICAID Introduce Hong Kong's First At-Home Health Test Monthly Subscription Service 2024-11-11 16:06
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases 2024-11-11 15:00
L'Oréal Showcases its Open Innovation Ecosystem Through Its Big Bang Beauty Tech Program at the 7th CIIE 2024-11-11 14:56
GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia 2024-11-11 10:58
Henlius and SVAX Forge Strategic Partnership in the MENAT Market 2024-11-09 00:35
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China'' 2024-11-08 22:30
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial 2024-11-08 16:30
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk 2024-11-07 21:37
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders 2024-11-07 16:29
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report 2024-11-06 16:09
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year 2024-11-06 15:56
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma 2024-11-06 15:20
Antengene Presents Results from Three Investigational Programs at the 2024 SITC Annual Meeting 2024-11-06 09:08
Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024 2024-11-06 08:30
The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024 2024-11-01 21:00
1 2 3 4 5 229